Thomas Walwyn
University of Western Australia
8 Papers
8 Citations
Thomas Walwyn is an academic researcher from University of Western Australia. The author has contributed to research in topics: Medicine & Quality of life. The author has an hindex of 4, co-authored 5 publications. Previous affiliations of Thomas Walwyn include Princess Margaret Hospital for Children.
Chat about Author
Papers
Medulloblastoma Down Under 2013: A report from the third annual meeting of the International Medulloblastoma Working Group.
Nicholas G. Gottardo,Nicholas G. Gottardo,Jordan R. Hansford,Jacqueline P. McGlade,Frank Alvaro,David M. Ashley,Simon Bailey,David L. Baker,Franck Bourdeaut,Yoon Jae Cho,Moira A Clay,Steven C. Clifford,Richard J. Cohn,Catherine H. Cole,Catherine H. Cole,Peter B. Dallas,Peter Downie,Peter Downie,François Doz,François Doz,David W. Ellison,Raelene Endersby,Paul G. Fisher,Tim Hassall,John A. Heath,Hilary Hii,David T.W. Jones,Reimar Junckerstorff,Reimar Junckerstorff,Stewart J. Kellie,Marcel Kool,Rishi S. Kotecha,Rishi S. Kotecha,Peter Lichter,Stephen J. Laughton,Sharon X. Lee,Geoff McCowage,Paul A. Northcott,James M. Olson,Roger J. Packer,Stefan M. Pfister,Torsten Pietsch,Barry Pizer,Scott L. Pomeroy,Marc Remke,Giles W. Robinson,Stefan Rutkowski,Tobias Schoep,Anang A. Shelat,Clinton F. Stewart,Michael J. Sullivan,Michael D. Taylor,Brandon J. Wainwright,Thomas Walwyn,William A. Weiss,Daniel Williamson,Amar Gajjar +56 more
TL;DR: A consensus was reached that a novel classification scheme for medulloblastoma based on the four molecular subgroups, as well as histopathologic features, should be presented for consideration in the upcoming fifth edition of the World Health Organization’s classification of tumours of the central nervous system.
“Forewarned and forearmed”: Long-term childhood cancer survivors’ and parents’ information needs and implications for survivorship models of care
Janine Vetsch,Janine Vetsch,Janine Vetsch,Joanna E. Fardell,Joanna E. Fardell,Claire E. Wakefield,Claire E. Wakefield,Christina Signorelli,Christina Signorelli,Gisela Michel,Jordana K. McLoone,Jordana K. McLoone,Thomas Walwyn,Heather Tapp,Jo Truscott,Richard J. Cohn,Richard J. Cohn +16 more
TL;DR: Unmet information needs were common for survivors and parents of CCS and future efforts towards tailoring information on potential late effects, healthy lifestyles and follow-up care may help to address un met information needs.
86
Long-term health-related quality of life in young childhood cancer survivors and their parents.
Joanna E. Fardell,Joanna E. Fardell,Claire E. Wakefield,Claire E. Wakefield,Richard De Abreu Lourenco,Christina Signorelli,Christina Signorelli,Maria C. McCarthy,Jordana K. McLoone,Jordana K. McLoone,Michael Osborn,Melissa Gabriel,Antoinette Anazodo,Antoinette Anazodo,Frank Alvaro,Liane Lockwood,Thomas Walwyn,Jane Skeen,Ramon Tillemans,Ramon Tillemans,Richard J. Cohn,Richard J. Cohn +21 more
TL;DR: In this article, the authors investigated the health-related quality-of-life (HRQoL) of young childhood cancer survivors and their parents and identified factors influencing child and parent HRQOLL.
29
Cardio-Oncology Recommendations for Pediatric Oncology Patients
Claudia Toro,Ben Felmingham,Sophie R Jessop,David S. Celermajer,Rishi S. Kotecha,Dinisha Govender,Diane Marie Terese Hanna,Matthew O'Connor,Rebecca Manudhane,Julian Ayer,John O'sullivan,Michael Sullivan,Ben Costello,Andre La Gerche,Thomas Walwyn,Lisa Horvath,Marion K. Mateos,Joy M. Fulbright,Mangesh Jadhav,Michael Cheung,David D. Eisenstat,David A. Elliott,Rachel Conyers +22 more
- 01 Dec 2022
TL;DR: In this paper , a rigorous Delphi consensus approach across 11 domains of cardio-oncology care using an Australian and New Zealand expert group is presented, which includes pediatric and adult cardiologists and pediatric oncologists.
7
Endemic Burkitt’s Lymphoma
Elizabeth Molyneux,Trijn Israels,Thomas Walwyn +2 more
- 01 Jan 2013
TL;DR: Endemic Burkitt’s lymphoma is the most common childhood tumour in parts of the world where malaria is holo-endemic and it is highly chemo-sensitive and cure rates are excellent if treated early and aggressively.
5